Oncology Targeted Methylation Panel 5 Gb (2000 x , 0.5 Mb Panel)

An oncology targeted methylation NGS panel is a molecular biology technique used to analyze the methylation patterns of specific genes associated with cancer development and progression. Methylation is a chemical modification of DNA that can regulate gene expression and is involved in many biological processes, including cancer. The panel typically includes genes that are commonly methylated in various types of cancer, including tumor suppressor genes and oncogenes. The panel can be designed using different sequencing technologies, including targeted sequencing, which focuses on specific regions of the genome, or whole exome sequencing, which sequences all protein-coding regions of the genome. The resulting sequence data can be analyzed to identify differentially methylated regions (DMRs) associated with various types of cancer. The information obtained from the panel can inform prognosis, identify potential therapeutic targets, and predict response to specific treatments. Oncology targeted methylation NGS panels have numerous applications in various fields of research, including cancer genomics, personalized medicine, and drug development. They can be used to identify biomarkers for cancer diagnosis and prognosis, develop targeted therapies, and investigate the molecular mechanisms underlying cancer development and progression. Oncology targeted methylation NGS panels are a powerful tool for understanding the epigenetic regulation of gene expression in cancer and its impact on cancer biology and treatment.